Effect of Repeated Glucagon Doses on Hepatic Glycogen in Type 1 Diabetes: Implications for a Bihormonal Closed-Loop System (Q36186004)

12 August 2017

Effect of Repeated Glucagon Doses on Hepatic Glycogen in Type 1 Diabetes: Implications for a Bihormonal Closed-Loop System (English)

1 reference

12 August 2017

0 references

1 reference

Jessica R Castle

1

1 reference

12 August 2017

Joseph El Youssef

2

1 reference

12 August 2017

Parkash A Bakhtiani

3

1 reference

12 August 2017

Yu Cai

4

1 reference

12 August 2017

Jade M Stobbe

5

1 reference

12 August 2017

Deborah Branigan

6

1 reference

12 August 2017

Katrina Ramsey

7

1 reference

12 August 2017

Peter Jacobs

8

1 reference

12 August 2017

Ravi Reddy

9

1 reference

12 August 2017

Mark Woods

10

1 reference

12 August 2017

W Kenneth Ward

11

1 reference

12 August 2017

language of work or name

English

0 references

publication date

4 September 2015

1 reference

12 August 2017

1 reference

12 August 2017

38

1 reference

12 August 2017

2115-2119

1 reference

12 August 2017

11

1 reference

Development of a highly stable, nonaqueous glucagon formulation for delivery via infusion pump systems

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4613914

Development of stable liquid glucagon formulations for use in artificial pancreas

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4613914

Factors affecting the success of glucagon delivered during an automated closed-loop system in type 1 diabetes.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4613914

A novel, stable, aqueous glucagon formulation using ferulic acid as an excipient

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4613914

Quantification of the glycemic response to microdoses of subcutaneous glucagon at varying insulin levels.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4613914

Accuracy of two continuous glucose monitoring systems: a head-to-head comparison under clinical research centre and daily life conditions

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4613914

Outpatient glycemic control with a bionic pancreas in type 1 diabetes

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4613914

Automated control of an adaptive bihormonal, dual-sensor artificial pancreas and evaluation during inpatient studies

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4613914

The artificial pancreas: current status and future prospects in the management of diabetes

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4613914

Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4613914

Stable liquid glucagon formulations for rescue treatment and bi-hormonal closed-loop pancreas

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4613914

Factors influencing the effectiveness of glucagon for preventing hypoglycemia

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4613914

Novel use of glucagon in a closed-loop system for prevention of hypoglycemia in type 1 diabetes

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4613914

Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4613914

Clinical pharmacokinetics and pharmacodynamics of insulin aspart

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4613914

Contributions of gluconeogenesis to glucose production in the fasted state

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4613914

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4613914

Direct observation of glycogen synthesis in human muscle with 13C NMR

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4613914

Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4613914

Role of hepatic glycogen breakdown in defective counterregulation of hypoglycemia in intensively treated type 1 diabetes

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4613914

Insulin kinetics in type-I diabetes: continuous and bolus delivery of rapid acting insulin.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4613914

Effect of blood sampling schedule and method of calculating the area under the curve on validity and precision of glycaemic index values

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4613914

Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4613914

Effects of short-term improvement of insulin treatment and glycemia on hepatic glycogen metabolism in type 1 diabetes.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4613914

Single dose glucagon (0.5 mg IV bolus) administration in healthy human volunteers is a robust model for assessment of glycogenolysis: characterisation of the glucose excursion after glucagon challenge

23 September 2018

1 reference

12 December 2020

13C NMR studies of glycogen turnover in the perfused rat liver

1 reference

12 December 2020

Validation of 13C NMR measurements of liver glycogen in vivo

1 reference

12 December 2020

Pharmacokinetic and glucodynamic comparisons of recombinant and animal-source glucagon after IV, IM, and SC injection in healthy volunteers

1 reference

12 December 2020

Automation control of blood sugar a servomechanism for glucose monitoring and control

1 reference

12 December 2020

Identifiers

DOI

10.2337/DC15-0754

1 reference

12 August 2017

1 reference

12 August 2017

1 reference